251 – 363 of 363
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2006
-
Mark
Chromosome 5 imbalance mapping in breast tumors from BRCA1 and BRCA2 mutation carriers and sporadic breast tumors
(
- Contribution to journal › Article
-
Mark
Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies
(
- Contribution to journal › Article
-
Mark
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
(
- Contribution to journal › Article
- 2005
-
Mark
High follicular phase luteinizing hormone levels in young healthy BRCA1 mutation carriers: Implications for breast and ovarian cancer risk.
(
- Contribution to journal › Article
-
Mark
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
(
- Contribution to journal › Article
-
Mark
Promoter usage of BRCA1-IRIS
(
- Contribution to journal › Letter
-
Mark
Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families.
(
- Contribution to journal › Article
-
Mark
Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing
(
- Contribution to journal › Article
-
Mark
Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to similar to 650 kb
(
- Contribution to journal › Article
-
Mark
Intratumor versus intertumor heterogeneity in gene expression profiles of soft-tissue sarcomas.
(
- Contribution to journal › Article
-
Mark
Analiza rokowniczego znaczenia mutacji genu TP53 u chorych na niedrobnokomorkowego raka pluca
(
- Contribution to journal › Article
-
Mark
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
(
- Contribution to journal › Article
-
Mark
Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations
(
- Contribution to journal › Article
-
Mark
PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma
(
- Contribution to journal › Article
-
Mark
Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
(
- Contribution to journal › Article
-
Mark
Classification of BRCA1 missense variants of unknown clinical significance
(
- Contribution to journal › Article
-
Mark
Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies
(
- Contribution to journal › Article
- 2004
-
Mark
Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation
(
- Contribution to journal › Article
-
Mark
Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
(
- Contribution to journal › Article
-
Mark
Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior.
(
- Contribution to journal › Article
-
Mark
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations : results of a prospective study in Southern Sweden
(
- Contribution to journal › Article
-
Mark
Melanoma and nonmelanoma skin cancer in patients with multiple tumours-evidence for new syndromes in a population-based study.
(
- Contribution to journal › Article
-
Mark
BRCA2 mutations in 154 Finnish male breast cancer patients
(
- Contribution to journal › Article
-
Mark
Predicting continuous values of prognostic markers in breast cancer from microarray gene expression profiles.
(
- Contribution to journal › Article
-
Mark
Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables
(
- Contribution to journal › Article
- 2003
-
Mark
Predicting the future of breast cancer.
(
- Contribution to journal › Letter
-
Mark
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status
(
- Contribution to journal › Scientific review
-
Mark
Expression profiling to predict outcome in breast cancer: the influence of sample selection
(
- Contribution to journal › Article
-
Mark
BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern Poland
(
- Contribution to journal › Article
-
Mark
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
(
- Contribution to journal › Article
-
Mark
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
(
- Contribution to journal › Article
-
Mark
Lack of HIN-1 methylation in BRCAl-linked and "BRCA1-like" breast tumors
(
- Contribution to journal › Article
-
Mark
Characterization of a novel breast carcinoma xenograft and cell line derived from a BRCA1 germ-line mutation carrier
(
- Contribution to journal › Article
-
Mark
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: A combined analysis of 22 studies
(
- Contribution to journal › Article
- 2002
-
Mark
Gene expression in inherited breast cancer
(
- Contribution to journal › Scientific review
-
Mark
A naturally occurring allele of BRCA1 coding for a temperature-sensitive mutant protein
(
- Contribution to journal › Article
-
Mark
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
(
- Contribution to journal › Article
-
Mark
Cancer Incidence in BRCA1 mutation carriers
(
- Contribution to journal › Article
-
Mark
Variation in BRCA1 cancer risks by mutation position
(
- Contribution to journal › Article
-
Mark
Bioarray software environment: a platform for comprehensive management and analysis of microarray data
(
- Contribution to journal › Article
-
Mark
BRCA1 and BRCA2 mutations among breast cancer patients from the Philippines
(
- Contribution to journal › Article
-
Mark
Clinical and histopathological features of malignant melanoma in germline CDKN2A mutation families
(
- Contribution to journal › Article
-
Mark
Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Chromosomal translocations involving 11q13 contribute to cyclin D1 overexpression in squamous cell carcinoma of the head and neck
(
- Contribution to journal › Article
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
-
Mark
Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy
(
- Contribution to journal › Article
-
Mark
A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes
(
- Contribution to journal › Article
- 2001
-
Mark
Hereditary prostate cancer: a new piece of the puzzle.
(
- Contribution to journal › Letter
-
Mark
Molecular and pathological characterization of inherited breast cancer.
(
- Contribution to journal › Article
-
Mark
First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm
(
- Contribution to journal › Article
-
Mark
Frequent somatic loss of BRCA1 in breast tumours from BRCA2 germ-line mutation carriers and vice versa
(
- Contribution to journal › Article
-
Mark
Two BRCA1-positive epithelial ovarian tumors with metastases to the central nervous system: a case report
(
- Contribution to journal › Article
-
Mark
Deletion mapping of chromosome segment 11q24-q25, exhibiting extensive allelic loss in early onset breast cancer
(
- Contribution to journal › Article
-
Mark
RESPONSE: Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
(
- Contribution to journal › Letter
-
Mark
BRCA2 mutation in a family with hereditary prostate cancer
(
- Contribution to journal › Article
-
Mark
The BRCA1 syndrome and other inherited breast or breast-ovarian cancers in a Norwegian prospective series
(
- Contribution to journal › Article
-
Mark
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns
(
- Contribution to journal › Article
-
Mark
Genetic epidemiology of BRCA1 mutations in Norway
(
- Contribution to journal › Article
-
Mark
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
(
- Contribution to journal › Article
-
Mark
Low frequency of E-cadherin alterations in familial breast cancer
(
- Contribution to journal › Article
-
Mark
BRCA1 and BRCA2 mutation status and cancer family history of Danish women affected with multifocal or bilateral breast cancer at a young age
(
- Contribution to journal › Article
-
Mark
Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families
(
- Contribution to journal › Article
-
Mark
Gene-expression profiles in hereditary breast cancer
(
- Contribution to journal › Article
-
Mark
DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis
(
- Contribution to journal › Article
- 2000
-
Mark
Somatic frameshift alterations in mononucleotide repeat-containing genes in different tumor types from an HNPCC family with germline MSH2 mutation
(
- Contribution to journal › Article
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
-
Mark
High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families
(
- Contribution to journal › Article
-
Mark
MYB oncogene amplification in hereditary BRCA1 breast cancer
(
- Contribution to journal › Article
-
Mark
Somatic deletions in hereditary breast cancers implicate 13q21 as a putative novel breast cancer susceptibility locus
(
- Contribution to journal › Article
- 1999
-
Mark
Reproductive factors in hereditary breast cancer
(
- Contribution to journal › Article
-
Mark
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Article
-
Mark
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
(
- Contribution to journal › Article
-
Mark
Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization
(
- Contribution to journal › Article
-
Mark
Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer
(
- Contribution to journal › Article
-
Mark
Somatic genetic alterations in BRCA2-associated and sporadic male breast cancer
(
- Contribution to journal › Article
-
Mark
Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations
(
- Contribution to journal › Article
-
Mark
Guidelines for follow-up of women at high risk for inherited breast cancer : consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Do BRCA1 mutations affect the ability to breast feed? Significantly shorter length of breast feeding among BRCA1 mutation carriers compared with their unaffected relatives.
(
- Contribution to journal › Article
-
Mark
Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers
(
- Contribution to journal › Letter
-
Mark
Survival of BRCA1 breast and ovarian cancer patients : a population-based study from southern Sweden
(
- Contribution to journal › Article
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article
-
Mark
BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease
(
- Contribution to journal › Article
-
Mark
Genetic aberrations in hypodiploid breast cancer: frequent loss of chromosome 4 and amplification of cyclin D1 oncogene
(
- Contribution to journal › Article
- 1997
-
Mark
Reduced testosterone, 17 beta-oestradiol and sexual hormone binding globulin, and increased insulin-like growth factor-1 concentrations, in healthy nulligravid women aged 19-25 years who were first and/or second degree relatives to breast cancer patients
(
- Contribution to journal › Article
-
Mark
Activated cell cycle checkpoints in epirubicin-treated breast cancer cells studied by BrdUrd-flow cytometry
(
- Contribution to journal › Article
-
Mark
Transcription of human endogenous retroviral sequences related to mouse mammary tumor virus in human breast and placenta : similar pattern in most malignant and nonmalignant breast tissues
(
- Contribution to journal › Article
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
-
Mark
Tumor Biological Features of BRCA1-Induced Breast Cancer
(
- Contribution to journal › Article
-
Mark
Tumour biological features of BRCA1-induced breast and ovarian cancer
(
- Contribution to journal › Article
-
Mark
Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer
(
- Contribution to journal › Article
-
Mark
Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations
(
- Contribution to journal › Article
- 1996
-
Mark
Genetic predisposition to breast cancer
(
- Contribution to journal › Article
-
Mark
Detection of Germline BRCA1 Mutations in Breast Cancer Patients by Quantitative Messenger RNA in situ Hybridization
(
- Contribution to journal › Article
-
Mark
Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer
(
- Contribution to journal › Article
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
-
Mark
Novel germline p16 mutation in familial malignant melanoma in southern Sweden
(
- Contribution to journal › Article
-
Mark
Founding BRCA1 Mutations in Hereditary Breast and Ovarian Cancer in Southern Sweden
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article
-
Mark
A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene : Implications for Presymptomatic Testing and Screening
(
- Contribution to journal › Article
- 1994
-
Mark
ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer
(
- Contribution to journal › Article
-
Mark
Cathepsin D, both a prognostic factor and a predictive factor for the effect of adjuvant tamoxifen in breast cancer. South Sweden Breast Cancer Group
(
- Contribution to journal › Article
- 1992
-
Mark
Chromosome I alterations in breast cancer : Allelic loss on Ip and Iq Is related to lymphogenic metastases and poor prognosis
(
- Contribution to journal › Article
-
Mark
c-myc amplification is an independent prognostic factor in postmenopausal breast cancer
(
- Contribution to journal › Article
-
Mark
The Retinoblastoma Gene in Breast Cancer : Allele Loss Is Not Correlated with Loss of Gene Protein Expression
(
- Contribution to journal › Article
-
Mark
Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome
(
- Contribution to journal › Article
-
Mark
Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas
(
- Contribution to journal › Article
-
Mark
Prognostic significance of flow cytometric DNA analysis and estrogen receptor content in breast carcinomas--a 10 year survival study
(
- Contribution to journal › Article
-
Mark
Flow cytometry DNA analysis and prediction of loco-regional recurrences after mastectomy in breast cancer
(
- Contribution to journal › Article
- 1991
-
Mark
HER-2/neu and INT2 proto-oncogene amplification in malignant breast tumors in relation to reproductive factors and exposure to exogenous hormones
(
- Contribution to journal › Article
-
Mark
ERBB2 amplification in breast cancer with a high rate of proliferation
(
- Contribution to journal › Article
-
Mark
DNA ploidy assessment of breast milk (colostrum) in primiparous women of different ages
(
- Contribution to journal › Article
- 1990
-
Mark
Indicators of prognosis in node-negative breast cancer
(
- Contribution to journal › Article
-
Mark
Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »